News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,530 Results
Type
Article (39380)
Company Profile (247)
Press Release (652903)
Section
Business (204027)
Career Advice (2005)
Deals (35404)
Drug Delivery (93)
Drug Development (80941)
Employer Resources (169)
FDA (16133)
Job Trends (14828)
News (344875)
Policy (32473)
Tag
Academia (2535)
Alliances (49314)
Alzheimer's disease (1314)
Approvals (16117)
Artificial intelligence (199)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (175)
Breast cancer (225)
Cancer (1710)
Cardiovascular disease (128)
Career advice (1669)
CAR-T (121)
Cell therapy (353)
Clinical research (65244)
Collaboration (659)
Compensation (370)
COVID-19 (2563)
C-suite (160)
Data (1629)
Diabetes (211)
Diagnostics (6282)
Earnings (85436)
Employer resources (146)
Events (110862)
Executive appointments (564)
FDA (17034)
Funding (602)
Gene therapy (245)
GLP-1 (648)
Government (4357)
Healthcare (18767)
Infectious disease (2674)
Interviews (310)
IPO (16460)
Job creations (3627)
Job search strategy (1420)
Layoffs (437)
Legal (7885)
Lung cancer (255)
Manufacturing (235)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (19319)
Metabolic disorders (548)
Neuroscience (1715)
NextGen: Class of 2025 (6509)
Non-profit (4475)
Northern California (2090)
Obesity (306)
Opinion (193)
Patents (162)
People (56828)
Phase I (20315)
Phase II (28745)
Phase III (21397)
Pipeline (711)
Postmarket research (2562)
Preclinical (8575)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5897)
Regulatory (21917)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1791)
Startups (3567)
United States (18436)
Vaccines (611)
Weight loss (208)
Date
Today (16)
Last 7 days (593)
Last 30 days (2573)
Last 365 days (34440)
2025 (4427)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (716)
Arizona (211)
Asia (37505)
Australia (6132)
California (4761)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80385)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Japan (121)
Maryland (739)
Massachusetts (3602)
Michigan (198)
Minnesota (334)
New Jersey (1347)
New York (1359)
North Carolina (833)
Northern California (2090)
Ohio (173)
Pennsylvania (1098)
South America (1093)
Southern California (1791)
Texas (701)
Utah (143)
Washington State (467)
692,530 Results for "biocardia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach
BioCardia ® , Inc. today announces that the Unites States Patent Office has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a patent term that will expire in 2036.
June 7, 2024
·
4 min read
Biotech Bay
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced the primary endpoint results of the open label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial.
May 1, 2024
·
5 min read
Press Releases
BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family
December 18, 2024
·
3 min read
Press Releases
BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions
January 27, 2025
·
3 min read
Biotech Bay
BioCardia Announces Reverse Stock Split - May 21, 2024
BioCardia, Inc. announced that, following approval by the Company’s stockholders and its Board of Directors, the Company intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 15 pre-split shares.
May 21, 2024
·
5 min read
Biotech Bay
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
BioCardia, Inc. and StemCardia, Inc. announced a long-term partnership to advance StemCardia’s investigational pluripotent stem cell product candidate for the treatment of heart failure.
March 13, 2024
·
4 min read
Business
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter of 2024 and filed its quarterly report on Form 10-Q for the three months ended March 31, 2024 with the Securities and Exchange Commission.
May 14, 2024
·
12 min read
Press Releases
BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure
December 4, 2024
·
3 min read
Press Releases
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)
February 14, 2025
·
7 min read
Press Releases
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results
November 14, 2024
·
10 min read
1 of 69,253
Next